4.7 Review

Chips for Biomaterials and Biomaterials for Chips: Recent Advances at the Interface between Microfabrication and Biomaterials Research

Journal

ADVANCED HEALTHCARE MATERIALS
Volume 10, Issue 14, Pages -

Publisher

WILEY
DOI: 10.1002/adhm.202100371

Keywords

biomaterials; high‐ throughput screening; microfabrication; microfluidics; organ‐ on‐ chip

Funding

  1. European Union Interreg Vlaanderen-Nederland project BIOMAT on microfluidic chip [0433]
  2. Dutch Province of Limburg (program Limburg INvesteert in haar Kenniseconomie/LINK) [SAS-2014-00837, SAS-2018-02477]
  3. Gravitation Program of the Netherlands Organisation for Scientific Research (NWO) (project Materials-Driven Regeneration) [024.003.013]
  4. NWO Incentive Grant for Women in STEM (Project Biotetris) [18748]
  5. NWO Vidi grant Bone Microfactory [15604]

Ask authors/readers for more resources

In recent years, the use of microfabrication techniques has allowed biomaterials studies to be miniaturized into on-chip experiments, offering various advantages. Biomaterial shapes and compositions are synthesized on chips, investigating interactions with biological systems, and applied in microfabricated devices to replicate physiological microenvironments. This trend towards increased scale and automation enables industrial production of micron-scale biomaterials and high-throughput screening, potentially leading to diverse applications.
In recent years, the use of microfabrication techniques has allowed biomaterials studies which were originally carried out at larger length scales to be miniaturized as so-called on-chip experiments. These miniaturized experiments have a range of advantages which have led to an increase in their popularity. A range of biomaterial shapes and compositions are synthesized or manufactured on chip. Moreover, chips are developed to investigate specific aspects of interactions between biomaterials and biological systems. Finally, biomaterials are used in microfabricated devices to replicate the physiological microenvironment in studies using so-called organ-on-chip, tissue-on-chip or disease-on-chip models, which can reduce the use of animal models with their inherent high cost and ethical issues, and due to the possible use of human cells can increase the translation of research from lab to clinic. This review gives an overview of recent developments at the interface between microfabrication and biomaterials science, and indicates potential future directions that the field may take. In particular, a trend toward increased scale and automation is apparent, allowing both industrial production of micron-scale biomaterials and high-throughput screening of the interaction of diverse materials libraries with cells and bioengineered tissues and organs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available